logo
3 European Growth Companies With Insider Ownership Up To 24%

3 European Growth Companies With Insider Ownership Up To 24%

Yahoo25-06-2025
As the European market navigates through geopolitical tensions and economic uncertainties, reflected by the recent declines in major indices like the STOXX Europe 600, investors are increasingly seeking stability and growth potential. In this environment, companies with high insider ownership can be particularly appealing as they often indicate management's confidence in their business prospects.
Name
Insider Ownership
Earnings Growth
Xbrane Biopharma (OM:XBRANE)
21.8%
56.8%
Redelfi (BIT:RDF)
12.1%
37.3%
Pharma Mar (BME:PHM)
11.8%
44.9%
MedinCell (ENXTPA:MEDCL)
13.9%
130.8%
KebNi (OM:KEBNI B)
38.3%
67%
Elliptic Laboratories (OB:ELABS)
24.4%
79%
Diamyd Medical (OM:DMYD B)
11.9%
93%
CTT Systems (OM:CTT)
17.5%
34.2%
Bonesupport Holding (OM:BONEX)
10.4%
58.6%
Bergen Carbon Solutions (OB:BCS)
12%
63.2%
Click here to see the full list of 190 stocks from our Fast Growing European Companies With High Insider Ownership screener.
We'll examine a selection from our screener results.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, furniture markets, and other industries globally, with a market cap of €940.56 million.
Operations: The company's revenue is segmented as follows: €176.26 million from the Americas, €134.84 million from Asia-Pacific, and €220.46 million from EMEA (Europe, Middle East and Africa).
Insider Ownership: 12.7%
Lectra's recent expansion of its Valia Fashion platform into new markets like Mexico and Brazil underscores its growth strategy in the fashion industry's shift to Industry 4.0. Despite a modest revenue growth forecast of 5.9% annually, Lectra's earnings are expected to grow significantly at 21.42% per year, outpacing the French market average. The company is exploring M&A opportunities to strengthen its position further while trading below estimated fair value, indicating potential for future appreciation.
Delve into the full analysis future growth report here for a deeper understanding of Lectra.
Our comprehensive valuation report raises the possibility that Lectra is priced lower than what may be justified by its financials.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Verve Group SE is a digital media company that provides ad-software solutions in North America and Europe, with a market cap of €528.13 million.
Operations: The company's revenue is derived from two main segments: Demand Side Platforms (DSP), generating €117.61 million, and Supply Side Platforms (SSP), contributing €401.53 million.
Insider Ownership: 24.5%
Verve Group SE's recent financial activities, including a SEK 360.024 million follow-on equity offering and board changes, highlight its dynamic growth strategy. Despite a drop in net income to €0.186 million for Q1 2025, revenue increased to €114.91 million compared to the previous year. The company anticipates annual revenues between €530 million and €565 million for 2025, with substantial insider buying indicating confidence in its growth potential despite volatile share prices and lower profit margins than last year.
Take a closer look at Verve Group's potential here in our earnings growth report.
According our valuation report, there's an indication that Verve Group's share price might be on the cheaper side.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €1.99 billion.
Operations: The company's revenue is divided into two main segments: DACH, generating €2.06 billion, and International, contributing €464.53 million.
Insider Ownership: 13.4%
Redcare Pharmacy's growth potential is underscored by substantial insider buying, indicating confidence despite a volatile share price. The company reported Q1 2025 sales of €717.29 million, up from €560.22 million the previous year, though it incurred a net loss of €10.82 million. With revenue forecasted to grow at 16% annually and expected profitability within three years, Redcare remains undervalued at 69% below its estimated fair value amid recent board changes enhancing strategic oversight.
Click here to discover the nuances of Redcare Pharmacy with our detailed analytical future growth report.
The analysis detailed in our Redcare Pharmacy valuation report hints at an inflated share price compared to its estimated value.
Unlock more gems! Our Fast Growing European Companies With High Insider Ownership screener has unearthed 187 more companies for you to explore.Click here to unveil our expertly curated list of 190 Fast Growing European Companies With High Insider Ownership.
Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include ENXTPA:LSS XTRA:M8G and XTRA:RDC.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Undiscovered European Gems With Strong Fundamentals July 2025
Undiscovered European Gems With Strong Fundamentals July 2025

Yahoo

time18 minutes ago

  • Yahoo

Undiscovered European Gems With Strong Fundamentals July 2025

As European markets show signs of resilience, with the STOXX Europe 600 Index climbing 1.32% amidst easing trade tensions and potential economic stimulus from Germany, investors are increasingly turning their attention to small-cap stocks that may not yet be on the radar. In this environment, identifying companies with robust fundamentals—such as strong balance sheets and sustainable growth prospects—can provide valuable opportunities for those looking to navigate the complexities of today's market landscape. Name Debt To Equity Revenue Growth Earnings Growth Health Rating AB Traction NA 5.39% 5.24% ★★★★★★ Caisse Régionale de Crédit Agricole Mutuel Brie Picardie Société coopérative 26.90% 4.14% 7.22% ★★★★★★ Martifer SGPS 102.88% -0.23% 7.16% ★★★★★★ La Forestière Equatoriale NA -65.30% 37.55% ★★★★★★ ABG Sundal Collier Holding 8.55% -4.14% -12.38% ★★★★★☆ Evergent Investments 5.39% 9.41% 21.17% ★★★★☆☆ Darwin 3.03% 84.88% 5.63% ★★★★☆☆ Practic 5.21% 4.49% 7.23% ★★★★☆☆ Inversiones Doalca SOCIMI 15.57% 6.53% 7.16% ★★★★☆☆ MCH Group 124.09% 12.40% 43.58% ★★★★☆☆ Click here to see the full list of 326 stocks from our European Undiscovered Gems With Strong Fundamentals screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Value Rating: ★★★★☆☆ Overview: Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire Société coopérative offers a range of banking products and services to diverse customer segments in France, with a market capitalization of approximately €579.37 million. Operations: CRLO generates revenue primarily from local banking in France (€234.80 million) and leasing activities (€151.14 million), with a smaller contribution from land-related operations (€1.13 million). With total assets of €15.2B and equity at €2.8B, Crédit Agricole Loire Haute-Loire stands out with its earnings growth of 14.9% over the past year, surpassing the industry average of 3.2%. The bank's liabilities are primarily low-risk customer deposits, making up 95% of its funding sources. However, it faces a challenge with a high level of bad loans at 3.2%, despite having a low allowance for these loans (82%). Trading at 29.1% below estimated fair value suggests potential upside if risks are managed effectively in this burgeoning financial landscape. Delve into the full analysis health report here for a deeper understanding of Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire Société coopérative. Gain insights into Caisse Régionale de Crédit Agricole Mutuel Loire Haute-Loire Société coopérative's past trends and performance with our Past report. Simply Wall St Value Rating: ★★★★★☆ Overview: Olvi Oyj is a beverage company that manufactures and sells alcoholic and non-alcoholic beverages across Finland, Estonia, Latvia, Lithuania, Denmark, and Belarus with a market cap of €700.73 million. Operations: Olvi Oyj generates revenue primarily from its alcoholic beverages segment, which accounts for €659.34 million. The company's financial performance is highlighted by a notable net profit margin trend, reflecting efficiency in managing costs relative to its revenue streams. Olvi, a Finnish beverage company, has shown impressive earnings growth of 14.8% over the past year, outpacing the broader beverage industry's 0.7%. The firm is trading at an attractive value, estimated to be 73.6% below its fair value compared to peers and industry standards. While Olvi's debt-to-equity ratio rose from 4.8% to 7.1% in five years, it remains financially robust with more cash than total debt and positive free cash flow of €48.51 million as of September 2024. Additionally, recent board changes include Nora Hortling as Chair and Lasse Heinonen as Vice Chair, enhancing governance dynamics. Get an in-depth perspective on Olvi Oyj's performance by reading our health report here. Learn about Olvi Oyj's historical performance. Simply Wall St Value Rating: ★★★★☆☆ Overview: Norion Bank AB (publ) offers financial solutions to medium-sized corporates, real estate companies, merchants, and private individuals across Sweden, Germany, Norway, Denmark, Finland, and internationally with a market cap of SEK10.45 billion. Operations: Norion Bank's primary revenue streams are derived from real estate (SEK1.22 billion), consumer (SEK930 million), corporate (SEK827 million), and payments (SEK501 million) segments. Norion Bank, with total assets of SEK67.6B and equity of SEK9.5B, operates primarily on low-risk funding from customer deposits, which make up 93% of its liabilities. Despite a high level of bad loans at 21.2%, the bank's earnings grew by 7.2% over the past year, surpassing the industry average decline of -1.5%. Trading at a substantial discount to its estimated fair value by 70.1%, Norion offers good relative value compared to peers in the industry while maintaining high-quality earnings despite challenges such as a low allowance for bad loans at only 49%. Click here and access our complete health analysis report to understand the dynamics of Norion Bank. Gain insights into Norion Bank's historical performance by reviewing our past performance report. Get an in-depth perspective on all 326 European Undiscovered Gems With Strong Fundamentals by using our screener here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:CRLO HLSE:OLVAS and OM:NORION. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

3 European Dividend Stocks Yielding Up To 5.8%
3 European Dividend Stocks Yielding Up To 5.8%

Yahoo

time18 minutes ago

  • Yahoo

3 European Dividend Stocks Yielding Up To 5.8%

As European markets experience a positive upswing, buoyed by easing trade tensions and potential economic stimulus in Germany, investors are increasingly looking towards dividend stocks as a reliable income source. In this environment of cautious optimism, selecting dividend stocks with stable yields can provide both income and a measure of stability amidst fluctuating market conditions. Name Dividend Yield Dividend Rating Zurich Insurance Group (SWX:ZURN) 4.43% ★★★★★★ Rubis (ENXTPA:RUI) 7.39% ★★★★★★ OVB Holding (XTRA:O4B) 4.59% ★★★★★★ Les Docks des Pétroles d'Ambès -SA (ENXTPA:DPAM) 5.73% ★★★★★★ Julius Bär Gruppe (SWX:BAER) 4.87% ★★★★★★ Holcim (SWX:HOLN) 5.31% ★★★★★★ ERG (BIT:ERG) 5.31% ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) 3.93% ★★★★★★ Banque Cantonale Vaudoise (SWX:BCVN) 4.79% ★★★★★★ Allianz (XTRA:ALV) 4.49% ★★★★★★ Click here to see the full list of 237 stocks from our Top European Dividend Stocks screener. We'll examine a selection from our screener results. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Italmobiliare S.p.A. is an investment holding company that manages a diverse portfolio of equity and other investments across financial and industrial sectors both in Italy and globally, with a market cap of €1.16 billion. Operations: Italmobiliare S.p.A.'s revenue is derived from several segments, including Caffè Borbone (€334.53 million), Italmobiliare itself (€140.15 million), Italgen (€66.80 million), Officina Profumo-Farmaceutica Di Santa Maria Novella (€69.97 million), Casa Della Salute (€63.23 million), SIDI Sport (€31.68 million), Clessidra Group (€45.16 million), Capitelli (€23.23 million), and Callmewine (€11.57 million). Dividend Yield: 3.3% Italmobiliare's dividend payments have shown stability and growth over the past decade, with a recent increase to €0.90 per share. Despite a low payout ratio of 40.6%, the dividends are not well covered by free cash flows, raising concerns about sustainability. The current yield of 3.29% is below top-tier Italian market payers, though earnings grew by 40.6% last year and are forecasted to continue growing at 15.84% annually, suggesting potential future support for dividends. Click here to discover the nuances of Italmobiliare with our detailed analytical dividend report. The valuation report we've compiled suggests that Italmobiliare's current price could be quite moderate. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Clínica Baviera, S.A. is a medical company that operates a network of ophthalmology clinics across Spain and Europe, with a market cap of €667.44 million. Operations: Clínica Baviera generates its revenue primarily from its ophthalmology segment, which accounts for €279.53 million. Dividend Yield: 3.8% Clínica Baviera's dividend payments have been volatile over the past decade, with a current yield of 3.77%, which is below the top tier in Spain. Despite this volatility, dividends are supported by earnings and cash flows, as indicated by payout ratios of 62.5% and 60%, respectively. The stock trades at a discount to its estimated fair value, while recent earnings growth—20.8% annually over five years—suggests potential for future stability in dividends. Navigate through the intricacies of Clínica Baviera with our comprehensive dividend report here. The analysis detailed in our Clínica Baviera valuation report hints at an deflated share price compared to its estimated value. Simply Wall St Dividend Rating: ★★★★★☆ Overview: Toyota Caetano Portugal, S.A. imports, assembles, and commercializes light and heavy vehicles with a market cap of €208.25 million. Operations: Toyota Caetano Portugal, S.A. generates revenue primarily through the commercialization of motor vehicles domestically (€824.71 million) and externally (€36.62 million), with additional contributions from external motor vehicles industry (€70.01 million), domestic motor vehicles services (€27.36 million), industrial equipment rental domestically (€13.96 million) and other smaller segments within the industrial equipment sector. Dividend Yield: 5.9% Toyota Caetano Portugal's dividend yield of 5.88% ranks in the top 25% of Portuguese dividend payers, yet its dividends have been volatile over the past decade. Despite this instability, recent earnings growth of 62.3% and low payout ratios—44.1% from earnings and 24% from cash flows—indicate strong coverage for current dividends. The stock is trading at a significant discount to its estimated fair value, suggesting potential value for investors seeking income amidst volatility concerns. Take a closer look at Toyota Caetano Portugal's potential here in our dividend report. Our expertly prepared valuation report Toyota Caetano Portugal implies its share price may be lower than expected. Navigate through the entire inventory of 237 Top European Dividend Stocks here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:ITM BME:CBAV and ENXTLS:SCT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

European Stocks That May Be Trading Below Estimated Value In July 2025
European Stocks That May Be Trading Below Estimated Value In July 2025

Yahoo

time18 minutes ago

  • Yahoo

European Stocks That May Be Trading Below Estimated Value In July 2025

As the European markets show signs of recovery, with the STOXX Europe 600 Index climbing 1.32% and Germany's DAX up by nearly 3%, investor optimism is bolstered by easing geopolitical tensions and potential economic stimulus measures. In this environment, identifying stocks that may be trading below their estimated value becomes crucial, as these opportunities can offer potential for growth when market conditions are favorable. Name Current Price Fair Value (Est) Discount (Est) Sulzer (SWX:SUN) CHF140.60 CHF278.20 49.5% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.30 €110.26 49.8% Ion Beam Applications (ENXTBR:IBAB) €11.56 €22.94 49.6% Società Benefit (BIT:ICOP) €13.30 €26.49 49.8% Green Oleo (BIT:GRN) €0.79 €1.57 49.6% Galderma Group (SWX:GALD) CHF115.50 CHF229.73 49.7% doValue (BIT:DOV) €2.42 €4.82 49.8% Cavotec (OM:CCC) SEK17.00 SEK33.89 49.8% Almirall (BME:ALM) €10.64 €21.21 49.8% ABO Energy GmbH KGaA (XTRA:AB9) €37.80 €75.09 49.7% Click here to see the full list of 189 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Overview: Maire S.p.A. develops and implements solutions for the energy transition, with a market cap of €3.68 billion. Operations: The company's revenue is primarily derived from Integrated E&C Solutions, generating €5.97 billion, and Sustainable Technology Solutions, contributing €376.94 million. Estimated Discount To Fair Value: 39.8% Maire S.p.A. is trading at €11.19, below its estimated fair value of €18.59, suggesting it may be undervalued based on cash flows. Recent earnings show a significant increase with net income rising to €61.54 million from €43.78 million year-over-year, and revenue growth outpacing the Italian market forecast at 6.8% annually compared to 4.1%. The company completed a follow-on equity offering of €51 million and expanded its cybersecurity services through Radware's solutions, enhancing operational resilience. Our expertly prepared growth report on Maire implies its future financial outlook may be stronger than recent results. Get an in-depth perspective on Maire's balance sheet by reading our health report here. Overview: Cellnex Telecom, S.A. operates in the management of terrestrial telecommunications infrastructures across several European countries including Austria, Denmark, and Spain, with a market cap of €24.05 billion. Operations: Cellnex Telecom generates its revenue from managing terrestrial telecommunications infrastructures in various European countries such as Austria, Denmark, and Spain. Estimated Discount To Fair Value: 45.5% Cellnex Telecom, trading at €34.09, is significantly below its estimated fair value of €62.57, highlighting potential undervaluation based on cash flows. The company recently completed a share buyback of 24.06 million shares for €800 million, which could enhance shareholder value. Despite forecasted slower revenue growth at 4.8% annually compared to the broader market's expectations, Cellnex is anticipated to achieve profitability in three years with robust earnings growth of 53.25% per year. Our growth report here indicates Cellnex Telecom may be poised for an improving outlook. Delve into the full analysis health report here for a deeper understanding of Cellnex Telecom. Overview: Truecaller AB (publ) develops and publishes mobile caller ID applications for individuals and businesses across India, the Middle East, Africa, and internationally, with a market cap of approximately SEK22.53 billion. Operations: The company's revenue is primarily generated from its Communications Software segment, which accounts for SEK1.95 billion. Estimated Discount To Fair Value: 32.1% Truecaller is trading at SEK65.4, significantly below its estimated fair value of SEK96.28, indicating it may be undervalued based on cash flows. The company forecasts robust earnings growth of 26.2% annually, surpassing the Swedish market's average. Recent initiatives like Secure Calls enhance business credibility and user trust, potentially driving future revenue growth of 19.4% per year. Additionally, Truecaller's share repurchase program aims to optimize capital structure and increase shareholder value over time. Insights from our recent growth report point to a promising forecast for Truecaller's business outlook. Click to explore a detailed breakdown of our findings in Truecaller's balance sheet health report. Reveal the 189 hidden gems among our Undervalued European Stocks Based On Cash Flows screener with a single click here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:MAIRE BME:CLNX and OM:TRUE B. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store